Recombinant BRD7 anticorps (AA 150-200)

N° du produit ABIN7449350

Détail du produit anti-BRD7 anticorps

Antigène: BRD7 (Bromodomain Containing 7 (BRD7))

Type d'anticorp: Recombinant Antibody

Épitope: AA 150-200

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp BRD7 est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS)

Fonction: Rabbit anti-BRD7 Recombinant Monoclonal Antibody [BLR220K]

Immunogène: between AA 150 and 200

Clone: BLR220K

Isotype: IgG

Information d'application

Indications d'application: 01:01,00

Restrictions: For Research Use only

Stockage

Concentration: 500 μg/mL

Buffer: Borate Buffered Saline (BBS) pH 8.2 with 0.1 % BSA and 0.09 % Sodium Azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Date de péremption: 12 months

Détails sur BRD7

Antigène: BRD7 (Bromodomain Containing 7 (BRD7))

Autre désignation: BRD7 (BRD7 Produits)

Synonymes: anticorps zgc:66347, anticorps wu:fc95f02, anticorps MGC79478, anticorps BRD7, anticorps BP75, anticorps CELTIX1, anticorps NAG4, anticorps Ptpn13ip, anticorps bromodomain containing 7 L homeolog, anticorps bromodomain containing 7, anticorps brd7.L, anticorps brd7, anticorps BRD7, anticorps Brd7

Sujet: Background: Bromodomain-containing protein 7 was identified in a two-hybrid screen as an interactor of interferon regulatory factor-2 (IRF-2) and called CELTIX1. BRD7 was also identified as a binding partner of disheveled-1 (Dvl-1) and found to play a role in Wnt signaling and the regulation of glycogen synthase kinase 3-beta activity. Recently, BRD7 was identified as a subunit of the polybromo-associated BRG1-associated factor (PBAF) complex and shown to be required for the modulation of transcription in embryonic stem cells.

ID gène: 29117

NCBI Accession: NP_037395

UniProt: Q9NPI1